S E M Vonk, PharmD1, S W J Terheggen-Lagro, MD,
PhD2, E G Haarman, MD, PhD2, H M
Janssens, MD, PhD3, A H Maitland – van der Zee,
PharmD, PhD3, E M Kemper, PharmD,
PhD1,4, R A A Mathôt, PharmD, PhD1on
behalf of the Amsterdam Mucociliary Clearance Disease (AMCD) research
group
- Amsterdam UMC location University of Amsterdam, Department of
Hospital Pharmacy & Clinical Pharmacology, Meibergdreef 9, Amsterdam,
The Netherlands
- Amsterdam UMC location University of Amsterdam, Emma Children’s
Hospital, Department of Pediatric Pulmonology and Allergy,
Meibergdreef 9, Amsterdam, The Netherlands
- Department of Pediatrics, Division of Respiratory Medicine and
Allergology, Erasmus MC-Sophia Children’s Hospital, University Medical
Center Rotterdam, Rotterdam, The Netherlands
- Amsterdam UMC location University of Amsterdam, Department of
Pulmonary Medicine, Meibergdreef 9, Amsterdam, The Netherlands
- Amsterdam UMC location University of Amsterdam, Department of
Vascular Medicine, Amsterdam, The Netherlands
Corresponding author:
S.E.M. Vonk, PharmD
Amsterdam UMC, location University of Amsterdam
Department of Hospital Pharmacy & Clinical Pharmacology
Meibergdreef 9
1105 AZ Amsterdam
Telephone: +31 (0)20 5669111
Email:
s.e.vonk@amsterdamumc.nl